A newly cleared point-of-care test will enable rapid identification of whooping cough, according to a press release from ...
Roche’s point-of-care polymerase chain reaction (PCR) test for pertussis and other Bordetella infections has received ...
See how QIAGEN’s flexible pipetting technologies optimize PCR sample preparation, enabling consistent results and faster ...
Basel: Roche has announced that its first point-of-care test for the diagnosis of whooping cough (pertussis) and other ...
THE Caribbean Public Health Agency (CARPHA) on Saturday handed over a state-of-the-art portable, mobile PCR instrument along ...
The point-of-care test delivers PCR-accurate results in just 15 minutes, enabling healthcare providers to act quickly and ...
Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...
Designed for use in doctor’s offices, clinics and emergency rooms, the PCR diagnostic aims to deliver results in fewer than ...
Roche AG received regulatory clearance from the U.S. and European authorities for a new diagnostic test that detects ...
Researchers develop a molecular testing-based fast-throughput method for the rapid and early detection of Salmonella ...
Roche gets US FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough: Basel Wednesday, December ...